Black Friday Special: Could 12/1 be the most profitable event in crypto history?
Man voted "#1 Most Trusted Crypto Expert" shares his latest buy recommendation.
Click For Special

BCDA Insider Trading (BioCardia)

Insider Ownership Percentage: 22.10%
Insider Buying (Last 12 Months): $31,364.00
Insider Selling (Last 12 Months): $0.00

BioCardia Insider Trading History Chart

This chart shows the insider buying and selling history at BioCardia by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioCardia Share Price & Price History

Current Price: $2.20
Price Change: Price Decrease of -0.03 (-1.35%)
As of 11/26/2021 01:00 AM ET

This chart shows the closing price history over time for BCDA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Black Friday Special: Could 12/1 be the most profitable event in crypto history?
Man voted "#1 Most Trusted Crypto Expert" shares his latest buy recommendation.
Click For Special

BioCardia Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2021Peter AltmanCEOBuy5,000$2.20$11,000.00View SEC Filing Icon  
8/17/2021Peter AltmanCEOBuy3,500$2.94$10,290.00232,909View SEC Filing Icon  
12/1/2020Peter AltmanCEOBuy1,000$2.49$2,490.00203,200View SEC Filing Icon  
11/27/2020Peter AltmanCEOBuy3,200$2.37$7,584.00203,200View SEC Filing Icon  
11/12/2020Peter AltmanCEOBuy2,000$2.07$4,140.00205,900View SEC Filing Icon  
11/10/2020Peter AltmanCEOBuy2,500$1.98$4,950.00203,900View SEC Filing Icon  
11/2/2020Eric DuckersInsiderSell8,435$2.01$16,954.3512,088View SEC Filing Icon  
6/19/2020Jim L AllenDirectorBuy142,850$2.10$299,985.00668,200View SEC Filing Icon  
3/24/2020Peter AltmanCEOBuy1,200$2.90$3,480.00171,911View SEC Filing Icon  
3/19/2020Peter AltmanCEOBuy400$2.95$1,180.00170,711View SEC Filing Icon  
3/12/2020Peter AltmanCEOBuy3,400$3.15$10,710.00166,811View SEC Filing Icon  
8/2/2019Simon H StertzerDirectorBuy166,666$6.00$999,996.00View SEC Filing Icon  
6/5/2019Peter AltmanInsiderBuy2,000$1.02$2,040.00View SEC Filing Icon  
5/28/2019Peter AltmanInsiderBuy200$1.28$256.00View SEC Filing Icon  
5/17/2019Peter AltmanInsiderBuy2,100$1.15$2,415.00View SEC Filing Icon  
5/1/2019Peter AltmanInsiderBuy11,000$1.08$11,880.00View SEC Filing Icon  
2/13/2019Peter AltmanInsiderBuy50$1.59$79.50View SEC Filing Icon  
12/24/2018Phillip Md Et Al FrostMajor ShareholderBuy2,000,000$0.75$1,500,000.00View SEC Filing Icon  
12/24/2018Simon H StertzerDirectorBuy3,333,332$0.75$2,499,999.00View SEC Filing Icon  
11/29/2018Simon H StertzerDirectorBuy1,000$2.10$2,100.00View SEC Filing Icon  
See Full Table
Insider Selling at BioCardia?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for BioCardia and related companies.

SEC Filings (Institutional Ownership Changes) for BioCardia (NASDAQ:BCDA)

22.22% of BioCardia stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BCDA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioCardia Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2021Millennium Management LLC10,015$31K0.0%N/A0.059%Search for SEC Filing on Google Icon
11/5/2021Advisor Group Holdings Inc.39,257$0.12M0.0%-8.4%0.233%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC16,492$51K0.0%N/A0.098%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC33,264$0.13M0.0%N/A0.197%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP21,680$86K0.0%-45.7%0.129%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP21,680$86K0.0%-45.7%0.129%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC102,230$0.41M0.0%-66.5%0.609%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC76,825$0.30M0.0%+23.6%0.457%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.411,969$1.64M0.0%+67.8%2.453%Search for SEC Filing on Google Icon
8/10/2021CM Management LLC329,000$1.31M0.9%+5.1%1.959%Search for SEC Filing on Google Icon
8/6/2021Magnus Financial Group LLC15,000$60K0.0%N/A0.089%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC46,945$0.20M0.0%N/A0.280%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC305,200$1.33M0.0%N/A1.817%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC62,168$0.27M0.0%+175.6%0.370%Search for SEC Filing on Google Icon
5/12/2021CM Management LLC313,100$1.36M1.0%+36.1%1.864%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp16,294$56K0.0%N/A0.131%Search for SEC Filing on Google Icon
2/5/2021CM Management LLC230,000$0.80M0.7%N/A1.851%Search for SEC Filing on Google Icon
8/17/2020Jane Street Group LLC14,688$35K0.0%N/A0.214%Search for SEC Filing on Google Icon
8/14/2020Captrust Financial Advisors659,179$1.62M0.0%N/A9.626%Search for SEC Filing on Google Icon
8/14/2020Advisor Group Holdings Inc.85,002$0.20M0.0%-7.7%1.241%Search for SEC Filing on Google Icon
5/18/2020Advisor Group Holdings Inc.92,083$0.31M0.0%N/A1.349%Search for SEC Filing on Google Icon
11/27/2019Millennium Management LLC41,978$0.14M0.0%N/A0.615%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioCardia logo
BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA.
Read More on BioCardia

Today's Range

Now: $2.20
Low: $2.13
High: $2.37

50 Day Range

MA: $2.82
Low: $2.05
High: $3.58

52 Week Range

Now: $2.20
Low: $2.05
High: $8.60

Volume

15,255 shs

Average Volume

160,979 shs

Market Capitalization

$37.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7

Who are the company insiders with the largest holdings of BioCardia?

BioCardia's top insider investors include:
  1. Jim L Allen (Director)
  2. Peter Altman (CEO)
  3. Eric Duckers (Insider)

Who are the major institutional investors of BioCardia?

BioCardia's top institutional shareholders include:
  1. Advisor Group Holdings Inc. — 0.23%
  2. Commonwealth Equity Services LLC — 0.10%
  3. HAP Trading LLC — 0.00%
  4. Millennium Management LLC — 0.06%
  5. Concourse Financial Group Securities Inc. — 0.00%

Which institutional investors are selling BioCardia stock?

During the previous quarter, BCDA stock was sold by these institutional investors:
  1. Advisor Group Holdings Inc.

Which institutional investors are buying BioCardia stock?

During the last quarter, BCDA stock was purchased by institutional investors including:
  1. Commonwealth Equity Services LLC
  2. HAP Trading LLC
  3. Millennium Management LLC
During the previous year, these company insiders have bought BioCardia stock:
  1. Jim L Allen (Director)
  2. Peter Altman (CEO)
Black Friday Special: Could 12/1 be the most profitable event in crypto history?
Man voted "#1 Most Trusted Crypto Expert" shares his latest buy recommendation.
Click For Special